Literature DB >> 21610006

Association studies in thyroid cancer susceptibility: are we on the right track?

Iñigo Landa1, Mercedes Robledo.   

Abstract

It is widely accepted that thyroid cancer is strongly determined by the individual genetic background. In this regard, it is expected that sporadic thyroid cancer is the result of multiple low- to moderate-penetrance genes interacting with each other and with the environment, thus modulating individual susceptibility. In the last years, an important number of association studies on thyroid cancer have been published, trying to determine this genetic contribution. The aim of this review is to provide a comprehensive and critical evaluation of the associations reported so far in thyroid cancer susceptibility in case-control studies performed in both non-medullary (papillary and follicular) and medullary thyroid cancers, including their potential strengths and pitfalls. We summarize the genetic variants reported to date, and stress the importance of validating the results in independent series and assessing the functional role of the associated loci.

Entities:  

Year:  2011        PMID: 21610006     DOI: 10.1530/JME-11-0005

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  23 in total

1.  The 8q24 rs6983267G variant is associated with increased thyroid cancer risk.

Authors:  Ruta Sahasrabudhe; Ana Estrada; Paul Lott; Lynn Martin; Guadalupe Polanco Echeverry; Alejandro Velez; Gila Neta; Meiko Takahasi; Vladimir Saenko; Norisato Mitsutake; Emma Jaeguer; Carlos Simon Duque; Alejandro Rios; Mabel Bohorquez; Rodrigo Prieto; Angel Criollo; Magdalena Echeverry; Ian Tomlinson; Luis G Carvajal Carmona
Journal:  Endocr Relat Cancer       Date:  2015-08-19       Impact factor: 5.678

2.  Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer.

Authors:  Briseis Aschebrook-Kilfoy; Gila Neta; Alina V Brenner; Amy Hutchinson; Ruth M Pfeiffer; Erich M Sturgis; Li Xu; William Wheeler; Michele M Doody; Stephen J Chanock; Alice J Sigurdson
Journal:  Endocr Relat Cancer       Date:  2012-05-24       Impact factor: 5.678

3.  Quantitative assessment of the association between L769L and S836S polymorphisms at RET gene and medullary thyroid carcinoma risk.

Authors:  Yuanqi Zhang; Sanming Wang; Xiaodong Chen; Shengchao Huang; Jianwen Li
Journal:  Tumour Biol       Date:  2014-04-04

4.  The Role of NRG1 in the Predisposition to Papillary Thyroid Carcinoma.

Authors:  Huiling He; Wei Li; Sandya Liyanarachchi; Yanqiang Wang; Lianbo Yu; Luke K Genutis; Sophia Maharry; John E Phay; Rulong Shen; Pamela Brock; Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

Review 5.  Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer.

Authors:  Mario E Lacouture; Kathryn Ciccolini; Richard T Kloos; Mark Agulnik
Journal:  Thyroid       Date:  2014-07-15       Impact factor: 6.568

6.  Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors.

Authors:  Delphine Vezzosi; Rossella Libé; Camille Baudry; Marthe Rizk-Rabin; Anelia Horvath; Isaac Levy; Fernande René-Corail; Bruno Ragazzon; Constantine A Stratakis; Grégoire Vandecasteele; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2012-09-20       Impact factor: 5.958

7.  Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).

Authors:  Joana S Pereira; Joana Gomes da Silva; Rute Alexandra Tomaz; António Evaristo Pinto; Maria João Bugalho; Valeriano Leite; Branca Maria Cavaco
Journal:  Endocrine       Date:  2014-11-09       Impact factor: 3.633

8.  Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.

Authors:  Huiling He; Wei Li; Sandya Liyanarachchi; Mukund Srinivas; Yanqiang Wang; Keiko Akagi; Yao Wang; Dayong Wu; Qianben Wang; Victor Jin; David E Symer; Rulong Shen; John Phay; Rebecca Nagy; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

9.  Association of the ATM gene polymorphisms with papillary thyroid cancer.

Authors:  Yulu Gu; Yaqin Yu; Lizhe Ai; Jieping Shi; Xiaoli Liu; Hui Sun; Yawen Liu
Journal:  Endocrine       Date:  2013-08-08       Impact factor: 3.633

10.  Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.

Authors:  Anna Wójcicka; Małgorzata Czetwertyńska; Michał Świerniak; Joanna Długosińska; Monika Maciąg; Agnieszka Czajka; Kinga Dymecka; Anna Kubiak; Adam Kot; Rafał Płoski; Albert de la Chapelle; Krystian Jażdżewski
Journal:  Genes Chromosomes Cancer       Date:  2014-03-06       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.